Shin Nippon Biomedical Laboratories (SNBL Japan, 株式会社 新日本科学) is a contract research organization specializing in preclinical and clinical studies. It offers GLP (good laboratory practice), toxicity, pathology, pharmacokinetics, translational, and other research services. The company serves the pharmaceutical industry.
|HQ||Chuo City, JP||Map|
Gross profit (H1, 2021)
Gross profit margin (H1, 2021), %
Net income (H1, 2021)
EBIT (H1, 2021)
Market capitalization (10-Nov-2021)
Closing stock price (10-Nov-2021)
|USD||Q1, 2019||Q2, 2019||Q3, 2019||Q1, 2020||Q2, 2020||Q3, 2020||Q1, 2021||Q2, 2021||Q3, 2021|
|Company Name||Date||Deal Size|
SNBL has 21 Twitter Followers. The number of followers has increased 1.5% quarter over quarter
When was SNBL founded?
SNBL was founded in 1957.
Who are SNBL key executives?
SNBL's key executives are Ryoichi Nagata, Hideshi Tsusaki and Satoshi Matsumoto.
How many employees does SNBL have?
SNBL has 1,005 employees.
What is SNBL revenue?
Latest SNBL annual revenue is $133.8 m.
What is SNBL revenue per employee?
Latest SNBL revenue per employee is $133.1 k.
Who are SNBL competitors?
Competitors of SNBL include Covance, Charles River Laboratories and Envigo.
Where is SNBL headquarters?
SNBL headquarters is located at St Luke's Tower 28F, 8-1 Akashi-cho, Chuo-ku, Tokyo,104-0044, Japan, Chuo City.
Where are SNBL offices?
SNBL has offices in Chuo City, Kagoshima, Kobe, Minato City and in 4 other locations.
How many offices does SNBL have?
SNBL has 8 offices.
Receive alerts for 300+ data fields across thousands of companies